Smitirupa Mishra: Standardizing RBC Morphology Reporting – Why ICSH Guidelines Matter?
Smitirupa Mishra, Consultant Pathologist at Sparsh Hospitals and Lab Head at Pathkind Labs, shared a post on LinkedIn:
“Standardizing RBC Morphology Reporting: Why ICSH Guidelines Matter
Red blood cell morphology remains one of the most valuable components of peripheral smear examination.
However, it is also one of the areas where significant inter-observer variability exists.
Terms such as ‘few’, ‘occasional’, ‘mild’, or ‘moderate’ may mean different things to different observers, leading to confusion among clinicians and inconsistency across laboratories.
This is where the International Council for Standardization in Haematology (ICSH) guidelines play a crucial role.
The ICSH recommendations provide a standardized framework for reporting RBC morphological abnormalities, including:
- Anisocytosis
- Microcytosis and Macrocytosis
- Hypochromia
- Target cells
- Elliptocytes
- Spherocytes
- Schistocytes
- RBC inclusions and other poikilocytes
By defining percentage-based grading criteria, the guidelines help:
- Reduce subjectivity in reporting
- Improve inter-laboratory consistency
- Enhance communication with clinicians
- Facilitate better patient management and follow-up
- Strengthen quality assurance practices in hematology laboratories
One particularly important aspect is the reporting of schistocytes, where even small percentages can have significant clinical implications and may point toward life-threatening thrombotic microangiopathies.
As laboratory professionals, adopting standardized reporting systems is not merely about compliance—it is about improving diagnostic accuracy and ensuring that every morphology report conveys clear, reproducible, and clinically meaningful information.
The next time you report an RBC morphology, ask yourself:
Are we describing what we see, or are we reporting it in a standardized manner that others can interpret consistently?
Standardization transforms morphology from an art into a reproducible science.”

Stay updated with Hemostasis Today.
-
Jul 16, 2026, 20:25Ilham Benzidia: Leaving ISTH 2026 With New Ideas and New Collaborations
-
Jul 16, 2026, 20:23Eman Hassan: A Fantastic Platelets and Megakaryocytes Session at ISTH 2026
-
Jul 16, 2026, 20:22Sankara Nelson Noah II: Investigating the Temporal Dynamics of Platelet – Leukocyte Interactions in Early Sepsis
-
Jul 16, 2026, 20:20Joseph Pierre Aboumsallem: Paris Certainly Delivered This Week, and Not Just Because of the Heat
-
Jul 16, 2026, 19:53Louise St. Germain Bannon: The End of Congress, the Beginning of New Collaborations
-
Jul 16, 2026, 19:18Steve Humphreys: Learning From the Leading Experts at ISTH 2026
-
Jul 16, 2026, 19:02Kellie Machlus: Where Science Meets Friendship at ISTH 2026
-
Jul 16, 2026, 18:51Aaron Paul Kithcart: When Clinical Research Comes Together at ISTH 2026
-
Jul 16, 2026, 18:40Sara Buonomo: Predicting Relapse in Immune-Mediated TTP at ISTH 2026